Nuzenio

Tradingview Phio Pharmaceuticals

Tradingview Phio Pharmaceuticals entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 4 latest news signals 1 publisher sources 100/100 entity strength

Latest news

Phio Pharmaceuticals Corp. Q2 2026: Net income $(4.14)M, EPS $(0.36) — 10-Q Summary - TradingViewTradingView · Thu, 06 Aug 2026 20:36:00 GMTPhio Pharmaceuticals posts $4.1M Q2 net loss, cash $13.0M; advances PH-762 program - TradingViewTradingView · Thu, 06 Aug 2026 20:35:16 GMTPHIO: Q2 2026 net loss widened to $4.1M as PH-762 advanced, with $13M in cash and ongoing funding needs - TradingViewTradingView · Thu, 06 Aug 2026 20:18:30 GMTPHIO Q2'26 Earnings: EPS estimate is (0.36) USD - TradingViewTradingView · Wed, 05 Aug 2026 11:02:01 GMT

Timeline

Thu, 06 Aug 2026 20:36:00 GMTPhio Pharmaceuticals Corp. Q2 2026: Net income $(4.14)M, EPS $(0.36) — 10-Q Summary - TradingView
Thu, 06 Aug 2026 20:35:16 GMTPhio Pharmaceuticals posts $4.1M Q2 net loss, cash $13.0M; advances PH-762 program - TradingView
Thu, 06 Aug 2026 20:18:30 GMTPHIO: Q2 2026 net loss widened to $4.1M as PH-762 advanced, with $13M in cash and ongoing funding needs - TradingView
Wed, 05 Aug 2026 11:02:01 GMTPHIO Q2'26 Earnings: EPS estimate is (0.36) USD - TradingView

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Tradingview Phio Pharmaceuticals.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.